Boule Diagnostics AB is a Swedish AB based in Spånga, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1996, the company reported revenue of SEK 28.9m in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna Tumbiolo, Simonetta i förening med externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, själv eller via dotterbolag, bedriva rörelse inom verksamheter med medicinsk- och bioteknisk inriktning, äga och förvalta lös och fast egendom samt annan därmed förenlig verksamhet.
In its most recent annual report (2024), Boule Diagnostics AB reported revenue of SEK 28.9m, a decrease of 60% on the year before. The figures on this page draw on 5 annual filings covering 2022 to 2024. The bottom line showed a net profit of SEK 74.3m, and the EBITDA margin stood at -19.9%.
At the end of 2024, equity financed 83.3% of the balance sheet, and current assets covered short-term debt 0.1 times.
Frequently asked questions
What is the Org number of Boule Diagnostics AB?
Boule Diagnostics AB is registered with Bolagsverket / SCB under Org 5565350252.
What is the revenue of Boule Diagnostics AB?
Boule Diagnostics AB reported revenue of SEK 28.9m in 2024.
Who is the CEO of Boule Diagnostics AB?
Simonetta Tumbiolo is the CEO of Boule Diagnostics AB, in role since 2026.
Who is the chairman of Boule Diagnostics AB?
Torben Jörgensen chairs the board of Boule Diagnostics AB, in role since 2023.
Where is Boule Diagnostics AB headquartered?
Boule Diagnostics AB's registered address is Fagerstagatan 7.
